January 18, 2017 / 6:12 PM / in a year

BUZZ-U.S. STOCKS ON THE MOVE-Target, CoLucid, Gigamon, Jazz Pharma

* Eikon search string for individual stock moves: STXBZ

* The Day Ahead newsletter: tmsnrt.rs/2ggOmBi

* The Morning News Call newsletter: tmsnrt.rs/2fwPLTh The S&P 500 and the Nasdaq were little changed in choppy trading on Wednesday as gains in tech stocks offset a weakness in retail sector, while the Dow was pulled lower by healthcare shares.

The Dow Jones Industrial Average was down 0.17 percent at 19,792.84, the S&P 500 was up 0.02 percent at 2,268.42 and the Nasdaq Composite was up 0.07 percent at 5,542.583.

** TARGET CORP, $66.80, -5.84 pct

The retailer became the latest U.S. brick-and-mortar chain to report disappointing results for the holiday season, cutting its quarterly earnings forecast after sales for the crucial November-December period came in lower than expected.

** COLUCID PHARMACEUTICALS INC, $46.25, +32.52 pct

** ELI LILLY AND CO, $77.55, +0.91 pct

Lilly said it would buy the migraine drug developer for about $960 million, bringing back into its fold a promising treatment for migraine, a large, under-treated market.

** GIGAMON INC, $30.75, -30.19 pct

The network traffic management software maker estimated its fourth-quarter revenue below its prior forecast, due to lower-than-expected product bookings in certain areas.

** APRICUS BIOSCIENCES INC, $3.84, +154.30 pct

The drug developer said Mexico has granted its commercialization partner, Ferring Pharmaceuticals, market approval for the company’s erectile dysfunction cream treatment, vitaros.

** SHILOH INDUSTRIES INC, $8.80, +12.97 pct

The automobile components maker turned an adjusted profit in the fourth quarter as it benefitted from a favorable product mix and operational efficiencies.

** ALCOA CORP, $34.51, +5.73 pct

** CENTURY ALUMINUM, $11.95, +3.82 pct

** TIMKENSTEEL CORP, $15.22, +3.96 pct

** COMMERCIAL METALS CO, $20.89, +4.03 pct

** STEEL DYNAMICS INC, $37.01, +3.93 pct

** NUCOR CORP, $61.96, +3.03 pct

U.S. steel and aluminum stocks rose after U.S. Commerce Secretary nominee Wilbur Ross said tariffs may be required to stop steel and aluminium dumping in the United States.

** TELADOC INC, $16.15, -7.18 pct

The telehealth services company is set to price its follow-on offering of 7.25 million share after market close.

** GRAY TELEVISION INC, $10.35, +2.99 pct

** DISH NETWORK CORP, $61.66, -0.80 pct

The television broadcast company reached an agreement with Dish, covering all of its owned and operated television stations across the United States.

** NXT-ID INC, $3.10, +16.10 pct

The mobile security service provider expects quarterly revenue of $4.5 million for the three months ended Dec. 31.

** BIG 5 SPORTING GOODS CORP, $15.10, -6.79 pct

The sporting goods retailer reported lower-than-expected fourth-quarter sales on Tuesday, hurt by a tough retail environment over the holiday selling period.

** TUESDAY CORP, $4.63, -7.50 pct

Brokerage Johnson Rice downgrades rating on the off-price retailer’s stock to “hold” from “accumulate.” The company said on Tuesday its COO resigned and it eliminated the COO post.

** SCORPIO BULKERS INC, $6.55, +9.17 pct

Brokerage Evercore ISI upgraded the dry bulk shipping company’s stock to “buy” from “hold.”

** XACTLY CORP, $12.55, +7.27 pct

Brokerage Craig-Hallum Capital Group LLC starts with a “buy” rating on the company whose software helps manage incentive compensation.

** URANIUM RESOURCES, $2.10, -9.87 pct

The uranium producer’s public offering of 1.4 million shares priced at $2.01 per share, represents a 14 percent discount to Tuesday’s close.

** REXX ENERGY CORP, $0.86, +15.44 pct

The oil producer’s two-year plan involves halving its capex in 2017, boosting production, trimming its costs and reducing its leverage ratio.

** BENITEC BIOPHARMA LTD, $2.35, -21.59 pct

The European Commission granted an orphan drug designation to Australian drug developer’s experimental drug, BB-301, for the treatment of a rare muscle wasting disorder.

** JAZZ PHARMACEUTICALS PLC, $128.26, +10.98 pct

The U.S. FDA on Tuesday granted the drugmaker’s petition to not approve any generic version of its sleep disorder drug Xyrem without a labeling package insert related to drug-drug interaction (DDI) with divalproex sodium.

** ATYR PHARMA INC, $3.22, +31.39 pct

The drug developer said its lead treatment, Resolaris, received a Fast Track designation by the FDA for the treatment of limb girdle muscular dystrophy 2B, a genetic disease caused by a toxic loss of function in the dysferlin gene.

** CAMECO CORP, $11.15, -15.98 pct

The Canadian uranium producer said on Tuesday it expected its 2016 adjusted profit to be significantly lower than analysts’ estimates and also said it would cut 120 jobs at three of its uranium mines in 2017.

** NORDSTROM INC, $43.70, -1.53 pct

Brokerage Credit Suisse upgraded Nordstrom’s stock to “outperform” from “buy”.

** JC PENNEY CO, $6.78, -2.31 pct

** KOHL‘S CORP, $40.80, -1.40 pct

** MACY‘S INC, $28.95, -3.19 pct

Brokerage Credit Suisse downgraded JC Penney and Kohl’s stock to “underperform” from “neutral” and cuts its price target on Macy’s stock.

** FASTENAL CO, $50.24, +4.11 pct

The industrial and fastener distributor’s earnings per share topped analysts’ estimates for the first time in five quarters as job cuts, store closures and cost controls pay off.

** WALT DISNEY CO, $108.00, +0.03 pct

Brokerage BMO downgraded the company’s stock to “underperform” from “market perform,” saying that challenges at ESPN remain.

** MERCANTILE BANK CORP, $32.65, -8.00 pct

Brokerage Raymond James downgraded the stock to “market perform” from “outperform.” (Compiled by Akankshita Mukhopadhyay in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below